240 related articles for article (PubMed ID: 12894601)
1. Three potentially fatal adverse effects of psychotropic medications.
Wren P; Frizzell LA; Keltner NL; Wright AV
Perspect Psychiatr Care; 2003; 39(2):75-81. PubMed ID: 12894601
[No Abstract] [Full Text] [Related]
2. [Malignant neuroleptic syndrome associated to risperidone].
Aguirre C; García Monco JC; Mendibil B
Med Clin (Barc); 1998 Feb; 110(6):239. PubMed ID: 9547739
[No Abstract] [Full Text] [Related]
3. Neuroleptic malignant syndrome with risperidone.
Gleason PP; Conigliaro RL
Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
[TBL] [Abstract][Full Text] [Related]
4. Risperidone and neuroleptic malignant syndrome.
Tarsy D
JAMA; 1996 Feb; 275(6):446. PubMed ID: 8627964
[No Abstract] [Full Text] [Related]
5. [Clozapine: an exclusive treatment?].
Vanelle JM
Encephale; 1992 Sep; 18 Spec No 3():441-5. PubMed ID: 1339761
[TBL] [Abstract][Full Text] [Related]
6. [Neuroleptic malignant syndrome-dopamine-serotonin syndrome--the physiopathology, diagnosis, and therapy].
Naito Y
Seishin Shinkeigaku Zasshi; 1997; 99(10):803-8. PubMed ID: 9465737
[No Abstract] [Full Text] [Related]
7. Neuroleptic malignant syndrome.
Bristow MF; Kohen D
Br J Hosp Med; 1996 Apr 17-30; 55(8):517-20. PubMed ID: 8732227
[TBL] [Abstract][Full Text] [Related]
8. Hyperthermia caused by drug interactions and adverse reactions.
Paden MS; Franjic L; Halcomb SE
Emerg Med Clin North Am; 2013 Nov; 31(4):1035-44. PubMed ID: 24176477
[TBL] [Abstract][Full Text] [Related]
9. [Etiologic mechanism of neuroleptic malignant syndrome--hypothesis of dopamine-serotonin imbalance].
Yamawaki N
Seishin Shinkeigaku Zasshi; 1988; 90(10):869-76. PubMed ID: 3251270
[No Abstract] [Full Text] [Related]
10. [Patient knowledge regarding Clozapine-induced agranulocytosis].
Haberfellner EM; Rittmannsberger H
Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
[No Abstract] [Full Text] [Related]
11. Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs.
Lieberman JA; Johns CA; Kane JM; Rai K; Pisciotta AV; Saltz BL; Howard A
J Clin Psychiatry; 1988 Jul; 49(7):271-7. PubMed ID: 3391979
[TBL] [Abstract][Full Text] [Related]
12. [Drug-induced neuroleptic malignant syndrome].
Kawanishi C; Furuno T; Kishida I
Nihon Rinsho; 2007 Oct; 65 Suppl 8():331-5. PubMed ID: 18074558
[No Abstract] [Full Text] [Related]
13. Neuroleptic Malignant Syndrome with ziprasidone.
Murty RG; Mistry SG; Chacko RC
J Clin Psychopharmacol; 2002 Dec; 22(6):624-6. PubMed ID: 12454565
[No Abstract] [Full Text] [Related]
14. Agranulocytosis monitoring with Clozapine patients: to follow guidelines or to attempt therapeutic controversies?
Chandrasekaran PK
Singapore Med J; 2008 Feb; 49(2):96-9. PubMed ID: 18301833
[TBL] [Abstract][Full Text] [Related]
15. AANA journal course. Update for nurse anesthetists. Neuroleptic malignant syndrome.
Waldorf S
AANA J; 2003 Oct; 71(5):389-94. PubMed ID: 14625976
[TBL] [Abstract][Full Text] [Related]
16. Atypical neuroleptic malignant syndrome with long-term clozapine.
Corallo CE; Ernest D
Crit Care Resusc; 2007 Dec; 9(4):338-40. PubMed ID: 18052897
[TBL] [Abstract][Full Text] [Related]
17. Psychotropic medications and falls in older adults.
Van Leuven K
J Psychosoc Nurs Ment Health Serv; 2010 Sep; 48(9):35-43. PubMed ID: 20795592
[TBL] [Abstract][Full Text] [Related]
18. [Risk minimization evolution of agranulocytosis caused by the administration of pharmaceutical products containing Clozapine in Argentina].
Bergman M; Bignone I; Bisio A; Bologna V; Sabatini A
Vertex; 2011; 22(96):94-7. PubMed ID: 21977603
[TBL] [Abstract][Full Text] [Related]
19. Managing patients with antipsychotic drug-induced hyperprolactinaemia.
Jones A; Jones M
Nurs Stand; 2008 Oct 15-21; 23(6):48-55; quiz 56. PubMed ID: 18988568
[TBL] [Abstract][Full Text] [Related]
20. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring.
Schulte P
Ann Pharmacother; 2006 Apr; 40(4):683-8. PubMed ID: 16595571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
